Never miss a Delaware County story!
Marinus Pharmaceuticals of Radnor saw its stock price plunge by more than 80 percent Monday because of a setback in an experimental seizure drug, writes…
The president of Cheyney University and the CEO of Radnor-based Marinus Pharmaceuticals made a Philadelphia Business Journal list of the 26 most admired CEOs…
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…
A Radnor pharmaceutical company specializing in new therapies for rare seizure disorders is raising $70 million through a public stock offering this week, writes John…
Radnor’s Marinus Pharmaceuticals is looking to raise $35 million from its public offering of 9.3 million shares of its common stock priced at…
Marinus Pharmaceuticals in Radnor is getting a jumpstart over the competition in the race to develop a treatment for the rare, autism-like Fragile X…
Before we send you to this site, please subscribe to our daily newsletter.